Dexrazoxane Intravenous and Insulin lispro Subcutaneous
Determining the interaction of Dexrazoxane Intravenous and Insulin lispro Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: Dexrazoxane
Generic Name: insulin lispro
Brand name: Admelog, Humalog, HumaLOG Pen, HumaLOG KwikPen, HumaLOG Cartridge, HumaLOG Junior KwikPen, Admelog SoloStar, Humalog
Synonyms: Insulin lispro, Insulin Lispro
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane Intravenous-Insulin NPH
- Dexrazoxane Intravenous-Insulin NPH (InnoLets, Pens, and PenFill Cartridges)
- Dexrazoxane Intravenous-Insulin NPH (Vials)
- Dexrazoxane Intravenous-Insulin NPH and Insulin Regular
- Dexrazoxane Intravenous-Insulin NPH and Insulin Regular (InnoLets, Pens, and PenFills)
- Dexrazoxane Intravenous-Insulin NPH and Insulin Regular (Vials)
- Insulin lispro Subcutaneous-Dextenza Insert
- Insulin lispro Subcutaneous-Dextenza intraocular
- Insulin lispro Subcutaneous-Dextran 40
- Insulin lispro Subcutaneous-Dextran 70 6% in 5% Dextrose high molecular weight
- Insulin lispro Subcutaneous-Dextran 75
- Insulin lispro Subcutaneous-Dextran high molecular weight